SCHEMBL10136867

SCHEMBL10136867

Cc1cc(Cl)cc(C(=O)NC(C)C)c1NC(=O)c1cc(CNS(=O)(=O)Cc2ccc(C(F)(F)F)cc2C(F)(F)F)nn1-c1ncccc1Cl

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 1/20 0.34
P2RX7 Q99572 1/20 0.32
ALDH1A1 P00352 2/20 0.32
KDM4E B2RXH2 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31
PTGDR2 Q9Y5Y4 1/20 0.31
MRGPRX4 Q96LA9 1/20 0.31
NTRK1 P04629 1/20 0.31
POLQ O75417 1/20 0.31
PTGER4 P35408 1/20 0.31
MALT1 Q9UDY8 1/20 0.31
UGCG Q16739 3/20 0.31
CYP3A4 P08684 2/20 0.31
CNR1 P21554 1/20 0.30
TRPV1 Q8NER1 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10136242 0.93 GRM4 (0.34) DHODHP2RX7ALDH1A1NTRK1PTGER4
SCHEMBL10136642 0.92 ALDH1A1 (0.35) DHODHALDH1A1MRGPRX4PTGER4UGCG
SCHEMBL10136627 0.91 ALDH1A1 (0.39) DHODHALDH1A1MRGPRX4NTRK1MALT1
SCHEMBL10136217 0.91 GRM4 (0.36) DHODHALDH1A1HPGDMRGPRX4MEN1
SCHEMBL10136641 0.90 ALDH1A1 (0.34) DHODHALDH1A1MRGPRX4MALT1UGCG
SCHEMBL10136243 0.89 ALDH1A1 (0.40) DHODHALDH1A1MAPTMRGPRX4NTRK1
SCHEMBL10136612 0.88 ALDH1A1 (0.35) DHODHALDH1A1MAPTUGCGCYP3A4
SCHEMBL10136626 0.87 POLB (0.37) DHODHALDH1A1KDM4EMAPTMEN1
SCHEMBL10118322 0.86 ALDH1A1 (0.35) DHODHALDH1A1MAPT
SCHEMBL10136313 0.86 HTR6 (0.36) DHODHP2RX7ALDH1A1NTRK1MALT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8791139-B2 Anthranilic diamide derivatives BAYER CROPSCIENCE AG (DE) 2014-07-29 US disclosed
US-20120015980-A1 ANTHRANILIC DIAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015980-A1 ANTHRANILIC DIAMIDE DERIVATIVES DDT, QDPR, ANTXR2 DHODH 197/4885P2RX7 802/4885ALDH1A1 732/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.